JP2001131042A - Oral composition - Google Patents
Oral compositionInfo
- Publication number
- JP2001131042A JP2001131042A JP31839799A JP31839799A JP2001131042A JP 2001131042 A JP2001131042 A JP 2001131042A JP 31839799 A JP31839799 A JP 31839799A JP 31839799 A JP31839799 A JP 31839799A JP 2001131042 A JP2001131042 A JP 2001131042A
- Authority
- JP
- Japan
- Prior art keywords
- mass
- calcium
- molecular weight
- average molecular
- oral composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 12
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims abstract description 11
- 229910052586 apatite Inorganic materials 0.000 claims abstract description 10
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 10
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims abstract description 9
- 229910052587 fluorapatite Inorganic materials 0.000 claims abstract description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 11
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 10
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 10
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 7
- XZMPQELFUMMFEI-UHFFFAOYSA-A [Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O Chemical group [Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XZMPQELFUMMFEI-UHFFFAOYSA-A 0.000 claims description 5
- 239000001506 calcium phosphate Substances 0.000 claims description 5
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 3
- 235000011010 calcium phosphates Nutrition 0.000 claims description 3
- -1 polyethylene Polymers 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 17
- 239000011575 calcium Substances 0.000 abstract description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052791 calcium Inorganic materials 0.000 abstract description 4
- 229910019142 PO4 Inorganic materials 0.000 abstract description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract description 2
- 239000010452 phosphate Substances 0.000 abstract description 2
- 229920001007 Nylon 4 Polymers 0.000 abstract 1
- 239000004698 Polyethylene Substances 0.000 abstract 1
- 229920000573 polyethylene Polymers 0.000 abstract 1
- 239000000551 dentifrice Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000000606 toothpaste Substances 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 230000001680 brushing effect Effects 0.000 description 5
- 229940034610 toothpaste Drugs 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 230000003631 expected effect Effects 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- YSJNWPJHMDWGAA-UHFFFAOYSA-H tricalcium;[oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O YSJNWPJHMDWGAA-UHFFFAOYSA-H 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 244000302899 Cassia mimosoides Species 0.000 description 1
- 235000014112 Cassia mimosoides Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 238000005602 Reppe reaction Methods 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006025 fining agent Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000008379 phenol ethers Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- VIZXMHCBZLGUET-UHFFFAOYSA-N sodium gualenate Chemical compound CC(C)C1=CC=C(C)C2=C(S(O)(=O)=O)C=C(C)C2=C1 VIZXMHCBZLGUET-UHFFFAOYSA-N 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- MBDOYVRWFFCFHM-UHFFFAOYSA-N trans-2-hexenal Natural products CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、ステイン除去効果
に優れた口腔用組成物に関する。TECHNICAL FIELD The present invention relates to an oral composition having an excellent stain removing effect.
【0002】[0002]
【従来の技術】従来より、歯磨剤組成物に、ステインの
溶解作用を有するポリエチレングリコール又はポリビニ
ルピロリドン等を配合し、歯面のステイン除去効果を高
めることも知られている。ここでステインとは、歯牙に
付着する色素沈着物のことであり、一般に喫煙やコーヒ
ー、紅茶、日本茶などの嗜好品の摂取によって蓄積され
るものである。しかしながら、ポリエチレングリコール
及びポリビニルピロリドンの2種類を単に混合しても十
分なステイン除去効果が得られない。ステイン除去効果
を有する口腔用組成物は種々提案されているものの、未
だ十分な効果を有した口腔用組成物は存在していない。
従って、優れたステイン除去効果を有する口腔用組成物
が望まれている。2. Description of the Related Art It has been conventionally known that a dentifrice composition is blended with polyethylene glycol or polyvinylpyrrolidone having a dissolving effect on stains to enhance the effect of removing stains on tooth surfaces. Here, the stain refers to pigment deposits attached to the teeth, and is generally accumulated by smoking or ingesting favorite items such as coffee, black tea, and Japanese tea. However, simply mixing the two types of polyethylene glycol and polyvinylpyrrolidone does not provide a sufficient stain removal effect. Although various oral compositions having a stain removing effect have been proposed, no oral compositions having a sufficient effect have yet been found.
Therefore, an oral composition having an excellent stain removing effect is desired.
【0003】[0003]
【発明が解決しようとする課題】本発明は、ステイン除
去効果に優れた口腔用組成物を提供することを目的とす
る。SUMMARY OF THE INVENTION An object of the present invention is to provide an oral composition having an excellent stain removing effect.
【0004】[0004]
【課題を解決するための手段】本発明者らは、上記課題
を解決すべく鋭意検討を行った結果、アパタイト類から
なる群より選ばれる少なくとも1種と、平均分子量20
0〜20,000のポリエチレングリコールと平均分子量
10,000〜360,000のポリビニルピロリドンとを
配合することによって、優れたステイン除去効果を付与
できることを見出した。従って本発明は、ヒドロキシア
パタイト、フルオロアパタイト、炭酸アパタイト、第三
リン酸カルシウム、第四リン酸カルシウム及び第八リン
酸カルシウムからなる群から選ばれる少なくとも1種を
0.1〜50質量%、平均分子量200〜20,000のポ
リエチレングリコールの少なくとも1種を0.1〜30質
量%、及び平均分子量10,000〜360,000のポリ
ビニルピロリドンの少なくとも1種を0.01〜3質量%
含有することを特徴とする口腔用組成物に関する。Means for Solving the Problems The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that at least one selected from the group consisting of apatites and an average molecular weight of 20
It has been found that an excellent stain removal effect can be imparted by blending polyethylene glycol of 0 to 20,000 with polyvinylpyrrolidone having an average molecular weight of 10,000 to 360,000. Accordingly, the present invention provides at least one selected from the group consisting of hydroxyapatite, fluorapatite, carbonate apatite, tribasic calcium phosphate, calcium tetraphosphate and calcium octaphosphate.
0.1 to 50% by weight, at least one kind of polyethylene glycol having an average molecular weight of 200 to 20,000 is 0.1 to 30% by weight, and at least one kind of polyvinylpyrrolidone having an average molecular weight of 10,000 to 360,000 is 0.001 to 3% by mass
The present invention relates to an oral composition characterized by containing the composition.
【0005】[0005]
【発明の実施の形態】本明細書中でいう口腔用組成物と
は、練歯磨剤、液状歯磨剤などの歯磨剤類、トローチ
剤、クリーム剤、軟膏剤、添付剤、マウスウォッシュ、
口中清涼剤、洗口剤、チューインガム又はうがい液など
を含む。本発明に用いるアパタイトとは、ヒドロキシア
パタイト、フルオロアパタイト、炭酸アパタイト、第三
リン酸カルシウム、第四リン酸カルシウム及び第八リン
酸カルシウムを意味する。本明細書中では、ヒドロキシ
アパタイト、フルオロアパタイト、炭酸アパタイト、第
三リン酸カルシウム、第四リン酸カルシウム及び第八リ
ン酸カルシウムを総称してアパタイト類と称する。それ
ぞれ以下の化学式によって表される。 ヒドロキシアパタイト:Ca10(PO4)6(OH)2 フルオロアパタイト:Ca10(PO4)6F2 炭酸アパタイト:CO3Ap 第三リン酸カルシウム:Ca3(PO4)2 第四リン酸カルシウム:Ca4O(PO4)2 第八リン酸カルシウム:Ca8(PO4)6・5H2O これらの中では、ヒドロキシアパタイトと第三リン酸カ
ルシウムが好ましく使用される。BEST MODE FOR CARRYING OUT THE INVENTION The oral composition referred to in the present specification includes dentifrices such as toothpaste and liquid dentifrice, troches, creams, ointments, attachments, mouthwash,
Including mouthwash, mouthwash, chewing gum or gargle. The apatite used in the present invention means hydroxyapatite, fluoroapatite, carbonate apatite, tribasic calcium phosphate, quaternary calcium phosphate and calcium octaphosphate. In the present specification, hydroxyapatite, fluoroapatite, carbonate apatite, tribasic calcium phosphate, calcium tetraphosphate and calcium octaphosphate are collectively referred to as apatites. Each is represented by the following chemical formula. Hydroxyapatite: Ca 10 (PO 4 ) 6 (OH) 2 Fluoroapatite: Ca 10 (PO 4 ) 6 F 2 Carbonate apatite: CO 3 Ap Calcium phosphate tribasic: Ca 3 (PO 4 ) 2 Quaternary calcium phosphate: Ca 4 O (PO 4) 2 eighth calcium: Ca 8 (PO 4) 6 · 5H 2 O among these, hydroxyapatite and tricalcium phosphate are preferably used.
【0006】これらのアパタイト類は、歯や骨の主成分
(無機成分)であり、生体親和性に優れた極めて安全性
の高い素材である。このため、ヒドロキシアパタイトや
第三リン酸カルシウムなどは生体材料として人工関節や
人工歯根などにも用いられる。また、ヒドロキシアパタ
イトは、カルシウムイオン、リン酸イオン、水酸化物イ
オンの位置が様々な微量元素と置換することが知られて
おり、水酸化物イオンがフッ素イオンに置換したものが
フルオロアパタイトとなり、結晶内に炭酸イオンが取り
込まれると炭酸アパタイトになる。アパタイトは一般に
合成品が用いられており、本発明においてもこのような
市販の合成品を用いることができる。これらは特に限定
されるものではないが、白色の水性懸濁液若しくは粉末
の状態で供給され、その平均粒子径は1〜70μmであ
る。[0006] These apatites are the main components (inorganic components) of teeth and bones, and are highly safe materials with excellent biocompatibility. For this reason, hydroxyapatite, tribasic calcium phosphate, and the like are used as biomaterials in artificial joints, artificial roots, and the like. Also, hydroxyapatite is known to replace calcium ions, phosphate ions, and hydroxide ions with various trace elements, and those in which hydroxide ions are replaced with fluorine ions become fluoroapatite, When carbonate ions are taken into the crystal, it becomes carbonate apatite. Synthetic products are generally used for apatite, and such commercially available synthetic products can also be used in the present invention. These are not particularly limited, but are supplied in the form of a white aqueous suspension or powder, and have an average particle size of 1 to 70 μm.
【0007】本発明の口腔用組成物におけるヒドロキシ
アパタイト、フルオロアパタイト、炭酸アパタイト、第
三リン酸カルシウム、第四リン酸カルシウム及び第八リ
ン酸カルシウムからなる群より選ばれる少なくとも1種
の含有量は、口腔用組成物の全質量に基づいて0.1〜5
0質量%が適当であり、好ましくは1〜30質量%であ
る。この量は0.1質量%に満たないと本発明が目的とす
る効果が十分に得られず、一方50質量%を超えても効
果の向上は見られない。In the oral composition of the present invention, the content of at least one selected from the group consisting of hydroxyapatite, fluoroapatite, carbonate apatite, tricalcium phosphate, calcium quaternary phosphate and calcium octaphosphate is 0.1 to 5 based on total mass
0 mass% is appropriate, and preferably 1 to 30 mass%. If this amount is less than 0.1% by mass, the desired effect of the present invention cannot be sufficiently obtained, while if it exceeds 50% by mass, no improvement in the effect is observed.
【0008】本発明で使用するポリエチレングリコール
は、水またはエチレングリコールに酸化エチレンを付加
させた重合体で、H(OCH2CH2)nOHで表される。この重
合体は酸化エチレンの付加量によって液状の低分子量の
ものから固体の高分子量のものまで各種分子量の重合物
ができ、その生成物は、種々の重合度のものが混合して
いる。ポリエチレングリコールはその平均分子量をもっ
て分類される。本発明では、平均分子量200〜20,0
00のポリエチレングリコールを1種あるいは2種以上
使用することができる。すなわち平均分子量が異なるも
のを2種以上使用してもよい。平均分子量が200に満
たないものは、期待される効果が発揮されず、一方平均
分子量が20,000を超えるものは剤形上配合が困難と
なる。The polyethylene glycol used in the present invention is a polymer obtained by adding ethylene oxide to water or ethylene glycol, and is represented by H (OCH 2 CH 2 ) nOH. Depending on the amount of ethylene oxide added, polymers of various molecular weights from liquid low molecular weight to solid high molecular weight can be formed, and the products are mixed with various degrees of polymerization. Polyethylene glycols are classified according to their average molecular weight. In the present invention, the average molecular weight is 200 to 200.0.
One or more polyethylene glycols can be used. That is, two or more compounds having different average molecular weights may be used. Those having an average molecular weight of less than 200 do not exhibit the expected effects, while those having an average molecular weight of more than 20,000 make it difficult to incorporate them in a dosage form.
【0009】このようなポリエチレングリコールは医薬
品や化粧品をはじめ、繊維・ゴム・接着剤・金属・窯業
・石油・印刷・インキ工業などに広く一般的に使用され
るものであり、本発明においてはこれらに使用されてい
る市販品を用いることができる。本発明の口腔用組成物
における1種あるいは2種以上のポリエチレングリコー
ルの含有量は、口腔用組成物の全質量に対して0.1〜3
0質量%、好ましくは0.5〜10質量%である。この量
が0.1質量%未満であると、期待される効果が発揮され
ず、一方30質量%を超えても含有量に見合った効果が
得られず使用性を損ねる場合がある。Such polyethylene glycol is widely and generally used in pharmaceuticals, cosmetics, fibers, rubbers, adhesives, metals, ceramics, petroleum, printing, inks, and the like. Commercially available products used in the above can be used. The content of one or more polyethylene glycols in the oral composition of the present invention is 0.1 to 3 with respect to the total mass of the oral composition.
0% by mass, preferably 0.5 to 10% by mass. If this amount is less than 0.1% by mass, the expected effect is not exhibited. On the other hand, if it exceeds 30% by mass, an effect commensurate with the content cannot be obtained and the usability may be impaired.
【0010】ポリビニルピロリドンは、アセチレンの高
圧合成法レッペ反応による合成化合物の一種であり、ビ
ニルピロリドンの直鎖重合体である。また、重合反応の
触媒量、温度、時間などにより本品の分子量は10,00
0〜700,000程度まで存在する。本発明では、平均
分子量10,000〜360,000のポリビニルピロリド
ンを1種あるいは2種以上使用することができる。すな
わち、平均分子量が異なるものを2種以上使用してもよ
い。平均分子量が360,000を超えるものは、剤形上
配合が困難となる。[0010] Polyvinylpyrrolidone is a kind of synthetic compound obtained by a high-pressure synthesis Reppe reaction of acetylene, and is a linear polymer of vinylpyrrolidone. In addition, the molecular weight of this product is 100,000 depending on the amount of catalyst for polymerization reaction, temperature, time and the like.
It exists up to about 0-700,000. In the present invention, one or more kinds of polyvinylpyrrolidone having an average molecular weight of 10,000 to 360,000 can be used. That is, two or more compounds having different average molecular weights may be used. Those having an average molecular weight of more than 360,000 are difficult to mix in a dosage form.
【0011】このようなポリビニルピロリドンは、医薬
品や化粧品を始め、織物・紙業・印刷・インキ工業・保
護塗料・飲料清澄剤・接着剤・農芸化学・プラスティッ
ク工業などに広く一般的に使用されるものであり、本発
明においてはこれらに使用されている市販品を用いるこ
とができる。本発明の口腔用組成物における1種あるい
は2種以上のポリビニルピロリドンの含有量は、口腔用
組成物の全質量に対して0.01〜3質量%、好ましくは
0.05〜1質量%である。この量が0.01質量%未満で
あると期待される効果が発揮されず、一方3質量%を超
えると含有量に見合った効果が得られず使用性を損ねる
場合がある。[0011] Such polyvinylpyrrolidone is widely and generally used in pharmaceuticals and cosmetics, as well as in the textile, paper industry, printing, ink industry, protective coatings, beverage fining agents, adhesives, agricultural chemistry, plastic industry, and the like. In the present invention, commercially available products used for these can be used. The content of one or more polyvinylpyrrolidone in the oral composition of the present invention is 0.01 to 3% by mass, preferably 0.03% by mass, based on the total mass of the oral composition.
0.05 to 1% by mass. If the amount is less than 0.01% by mass, the expected effect is not exhibited, while if it exceeds 3% by mass, the effect corresponding to the content cannot be obtained and the usability may be impaired.
【0012】本発明の口腔用組成物において、配合する
ポリエチレングリコールの総質量とポリビニルピロリド
ンの総質量の比は、1:30〜3,000:1の広範囲で
使用することができ、さらに1:30〜1,000:1、
好ましくは1:30〜300:1、より好ましくは1:
30〜200:1の範囲である。In the oral composition of the present invention, the ratio of the total mass of polyethylene glycol to the total mass of polyvinyl pyrrolidone to be blended can be used in a wide range of from 1:30 to 3,000: 1, and more preferably from 1:30 to 3,000: 1. 30-1,000: 1,
Preferably 1: 30-300: 1, more preferably 1: 1.
The range is 30 to 200: 1.
【0013】本発明の口腔用組成物にはその種類に応じ
て、上記成分に加えて、必要により以下の成分を通常の
使用量の範囲内で配合することができる。 <研磨剤>シリカゲル、沈降性シリカ、火成性シリカ、
含水ケイ酸、無水ケイ酸、ゼオライト、アルミノシリケ
ート、ジルコノシリケート等のシリカ系研磨剤、第二リ
ン酸カルシウム二水和物、第二リン酸カルシウム無水和
物、ピロリン酸カルシウム、第三リン酸マグネシウム、
水酸化アルミニウム、アルミナ、軽質炭酸カルシウム、
重質炭酸カルシウム、炭酸マグネシウム、ケイ酸ジルコ
ニウム、合成樹脂系研磨剤などが挙げられ、これらのう
ち1種または2種以上を併用して用いることができる。
上記研磨剤の配合量は、組成物全体に対して3〜60質
量%が好ましく、より好ましくは10〜45質量%であ
る。The oral composition of the present invention may contain, in addition to the above components, the following components, if necessary, within the usual range of use, depending on the type of the composition. <Abrasives> Silica gel, precipitated silica, igneous silica,
Silica-based abrasives such as hydrous silicic acid, silicic anhydride, zeolite, aluminosilicate, zirconosilicate, dibasic calcium phosphate dihydrate, dibasic calcium phosphate anhydrate, calcium pyrophosphate, tertiary magnesium phosphate,
Aluminum hydroxide, alumina, light calcium carbonate,
Examples thereof include heavy calcium carbonate, magnesium carbonate, zirconium silicate, and a synthetic resin-based abrasive, and one or more of these can be used in combination.
The compounding amount of the above-mentioned abrasive is preferably 3 to 60% by mass, more preferably 10 to 45% by mass, based on the whole composition.
【0014】<湿潤剤>グリセリン、濃グリセリン、ジ
グリセリン、ソルビット、マルチトール、ジプロピレン
グリコール、プロピレングリコール、1,3-ブチレングリ
コール、キシリトール等の多価アルコール等の1種また
は2種以上を使用することができる。 <粘結剤>カラギーナン(ι、λ、κ)、アルギン酸、
アルギン酸ナトリウム、アルギン酸プロピレングリコー
ルエステル、カルシウム含有アルギン酸ナトリウム、ア
ルギン酸カリウム、アルギン酸カルシウム、アルギン酸
アンモニウム等のアルギン酸塩及びその誘導体、キサン
タンガム、グァーガム、ゼラチン、寒天、カルボキシメ
チルセルロースナトリウム、ヒドロキシエチルセルロー
ス、ポリアクリル酸ナトリウムなどが挙げられ、これら
のうち1種または2種以上を併用して用いることができ
る。<Wetting agent> One or more kinds of polyhydric alcohols such as glycerin, concentrated glycerin, diglycerin, sorbitol, maltitol, dipropylene glycol, propylene glycol, 1,3-butylene glycol and xylitol are used. can do. <Binder> carrageenan (ι, λ, κ), alginic acid,
Alginate such as sodium alginate, propylene glycol alginate, sodium alginate containing calcium, potassium alginate, calcium alginate, ammonium alginate and derivatives thereof, xanthan gum, guar gum, gelatin, agar, sodium carboxymethyl cellulose, hydroxyethyl cellulose, sodium polyacrylate, etc. These may be used alone or in combination of two or more.
【0015】<発泡剤>ラウリル硫酸ナトリウム、ラウ
ロイルサルコシンナトリウム、アルキルスルホコハク酸
ナトリウム、ヤシ油脂肪酸モノグリセリンスルホン酸ナ
トリウム、α-オレフィンスルホン酸ナトリウム、N-ア
シルグルタメート等のN-アシルアミノ酸塩、2-アルキル
-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニ
ウムベタイン、マルチトール脂肪酸エステル、ショ糖脂
肪酸エステル、ポリグリセリン脂肪酸エステル、脂肪酸
ジエタノールアミド、ポリオキシエチレンソルビタンモ
ノステアレート、ポリオキシエチレン硬化ヒマシ油、ポ
リオキシエチレン脂肪酸エステル等が挙げられ、これら
のうち1種または2種以上を併用して用いることができ
る。<Effervescent agent> N-acyl amino acid salts such as sodium lauryl sulfate, sodium lauroyl sarcosine, sodium alkyl sulfosuccinate, sodium coconut fatty acid monoglycerin sulfonate, sodium α-olefin sulfonate, N-acyl glutamate, Alkyl
-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, maltitol fatty acid ester, sucrose fatty acid ester, polyglycerin fatty acid ester, fatty acid diethanolamide, polyoxyethylene sorbitan monostearate, polyoxyethylene hydrogenated castor oil, poly Oxyethylene fatty acid esters and the like can be mentioned, and one or more of these can be used in combination.
【0016】<甘味剤>サッカリンナトリウム、アスパ
ルテーム、ステビオサイド、ステビアエキス、パラメト
キシシンナミックアルデヒド、ネオヘスペリジルジヒド
ロカルコン、ペリラルチン等。 <防腐剤>メチルパラベン、エチルパラベン、プロピル
パラベン、ブチルパラベン等のパラベン類、安息香酸ナ
トリウム、フェノキシエタノール、塩酸アルキルジアミ
ノエチルグリシン等。<Sweetening agents> Saccharin sodium, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidyl dihydrochalcone, perillartin and the like. <Preservatives> Parabens such as methylparaben, ethylparaben, propylparaben, and butylparaben, sodium benzoate, phenoxyethanol, and alkyldiaminoethylglycine hydrochloride.
【0017】<香料成分>l-メントール、アネトール、
メントン、シネオール、リモネン、カルボン、メチルサ
リシレート、エチルブチレート、オイゲノール、チモー
ル、シンナミックアルデヒド、トランス-2-ヘキセナー
ルなどの中から1種または2種以上を併用して用いるこ
とができる。これらの成分は単品で配合してもよいが、
これらを含有する精油等を配合してもよい。また、上記
香料成分に加え、脂肪族アルコールやそのエステル、テ
ルペン系炭化水素、フェノールエーテル、アルデヒド、
ケトン、ラクトン等の香料成分、精油を本発明の効果を
妨げない範囲で配合してもよい。上記香料の配合量は、
組成物全体に対して0.02〜2質量%とすることが好ま
しい。<Fragrance ingredients> l-menthol, anethole,
One or more of menthone, cineole, limonene, carvone, methyl salicylate, ethyl butyrate, eugenol, thymol, cinamic aldehyde, trans-2-hexenal and the like can be used in combination. These components may be compounded individually,
Essential oils containing these may be blended. Further, in addition to the above flavor components, aliphatic alcohols and esters thereof, terpene hydrocarbons, phenol ethers, aldehydes,
Perfume components such as ketones and lactones, and essential oils may be blended as long as the effects of the present invention are not impaired. The amount of the above fragrance is
The content is preferably set to 0.02 to 2% by mass based on the whole composition.
【0018】<有効成分>塩化リゾチーム、モノフルオ
ロホスフェート、フッ化ナトリウム、フッ化カリウム、
モノフルオロリン酸ナトリウム、ヒノキチオール、アス
コルビン酸、クロルヘキシジン塩類、トリクロサン、イ
ソプロピルメチルフェノール、塩化セチルピリジニウ
ム、塩化ベンザルコニウム、塩化ベンゼトニウム、ビサ
ボロール、酢酸トコフェロール、ε−アミノカプロン
酸、トラネキサム酸、アルミニウムヒドロキシルアラン
トイン、乳酸アルミニウム、ジヒドロコレステロール、
グリチルレチン酸、グリチルリチン酸塩類、銅クロロフ
ィリン塩、塩化ナトリウム、グァイアズレンスルホン酸
塩、デキストラナーゼ、ゼオライト、塩酸ピリドキシン
などを1種または2種以上を配合することができる。<Active ingredient> Lysozyme chloride, monofluorophosphate, sodium fluoride, potassium fluoride,
Sodium monofluorophosphate, hinokitiol, ascorbic acid, chlorhexidine salts, triclosan, isopropylmethylphenol, cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, bisabolol, tocopherol acetate, ε-aminocaproic acid, tranexamic acid, aluminum hydroxyl allantoin, lactic acid Aluminum, dihydrocholesterol,
One or more of glycyrrhetinic acid, glycyrrhizinates, copper chlorophyllin salts, sodium chloride, guaiazulene sulfonate, dextranase, zeolite, pyridoxine hydrochloride and the like can be blended.
【0019】<その他>青色1号等の色素、酸化チタン
等の顔料、ジブチルヒドロキシトルエン等の酸化防止
剤、エデト酸塩等のキレート剤、チャエキス、チャ乾留
液、プロポリスエキス、グルタミン酸ナトリウム等の矯
味剤など。なお、本発明の口腔用組成物は、常法に準じ
て製造できるものであり、その製法は特に限定されるも
のではない。また、得られた練歯磨剤等の口腔用組成物
は、アルミニウムチューブ、ラミネートチューブ、ガラ
ス蒸着チューブ、プラスチックチューブ、プラスチック
ボトル、エアゾール容器等に充填されて使用することが
できる。<Others> Pigments such as Blue No. 1, pigments such as titanium oxide, antioxidants such as dibutylhydroxytoluene, chelating agents such as edetate, tea extract, tea distillation, propolis extract, sodium glutamate, etc. Agents and the like. The oral composition of the present invention can be produced according to a conventional method, and the production method is not particularly limited. The obtained oral composition such as toothpaste can be used after being filled in an aluminum tube, a laminate tube, a glass deposition tube, a plastic tube, a plastic bottle, an aerosol container, or the like.
【0020】[0020]
【発明の効果】本発明の口腔用組成物は、ステイン除去
効果に優れたものである。The oral composition of the present invention has an excellent stain removing effect.
【0021】[0021]
【実施例】以下、実験例及び実施例により、本発明を詳
細に説明するが、本発明は下記の実施例に制限されるも
のではない。表1〜3に示す組成(単位:質量%)にて
常法により各種練歯磨剤を調製し、以下の試験に供し
た。なお、組成中のポリビニルピロリドンK30は重合
度約40,000であり、ポリビニルピロリドンK90は
重合度約360,000である。 <ステイン除去試験1>上記の各種練歯磨剤10gにイ
オン交換水25gを加えて均一に分散させた歯磨剤分散
液を試験に用いた。内径15×7×7cmのアクリルケー
ス内中央に、予めタバコより抽出したタールを前面全体
に塗布したヒト抜去歯(上顎前歯)を、タール塗布面を
上にして固定し、そこへ上記歯磨剤分散液を30g注ぎ
入れた。通常一般に市販されている歯ブラシを装着した
歯磨剤用研磨性試験器に、上記アクリルケースを固定
し、ブラッシング加重200g、ブラッシング回数10
0ストローク、ストローク幅10cmで人工ブラッシング
を行った。ブラッシング終了後、流水で歯磨剤分散液を
洗い流したヒト抜去歯を披験試料とした。披験試料は下
記の評価基準に基づいて、ステイン除去の目視による官
能評価を行った。EXAMPLES The present invention will be described in detail below with reference to experimental examples and examples, but the present invention is not limited to the following examples. Various toothpastes were prepared by the usual method using the compositions (unit: mass%) shown in Tables 1 to 3, and subjected to the following tests. In the composition, polyvinylpyrrolidone K30 has a degree of polymerization of about 40,000, and polyvinylpyrrolidone K90 has a degree of polymerization of about 360,000. <Stain removal test 1> A dentifrice dispersion obtained by adding 25 g of ion-exchanged water to 10 g of the above-mentioned various toothpastes and uniformly dispersing the same was used for the test. In the center of an acrylic case with an inner diameter of 15 x 7 x 7 cm, a human extracted tooth (maxillary anterior tooth) with tar extracted from tobacco applied on the entire front surface is fixed with the tar applied surface facing up, and the dentifrice is dispersed there. 30 g of the liquid was poured. Normally, the above-mentioned acrylic case was fixed to an abrasive tester for dentifrice equipped with a commercially available toothbrush, and the weight of brushing was 200 g and the number of times of brushing was 10
Artificial brushing was performed with 0 stroke and a stroke width of 10 cm. After the brushing was completed, a human extracted tooth from which the dentifrice dispersion was washed away with running water was used as a test sample. The test samples were subjected to visual sensory evaluation of stain removal based on the following evaluation criteria.
【0022】「評価基準」 ステイン除去度合い ◎・・・・・完全にステインが除去されている。 ○・・・・・ほとんどステインが除去されている。 △・・・・・ややステインが除去されている。 ×・・・・・全くステインが除去されていない。 このステイン除去試験1の結果も表1〜3に併せて示
す。"Evaluation Criteria" Stain removal degree ◎: Stain is completely removed.・: Most stains are removed. △ ・ ・ ・ ・ ・ Stain was slightly removed. ×: No stain was removed at all. The results of the stain removal test 1 are also shown in Tables 1 to 3.
【0023】[0023]
【表1】 [Table 1]
【0024】[0024]
【表2】 [Table 2]
【0025】[0025]
【表3】 [Table 3]
【0026】<ステイン除去試験2> (1)タール含有量10mg以上のタバコを1日20本以上喫
煙することを習慣としている男性10名を被験者とし
た。被験者10名のうち5名は、実施例1の歯磨剤、残
り5名は比較例1の歯磨剤を使用して、1週間、1日2
回、3分程度通常の歯みがきを行った。1週間の使用試
験終了後、各被験者に対して、下記評価基準を記載した
アンケートを行った。1ヶ月のブランクを経た後、再び
同様の使用試験を行い、同様のアンケートを行った。1
回目の使用試験で実施例1の歯磨剤を使用した群は、比
較例1の歯磨剤を、1回目の使用試験で比較例1の歯磨
剤を使用した群は実施例1の歯磨剤を使用することとし
た。 (2)上記の試験(1)と同様の手順で、実施例3の歯磨剤と
比較例3の歯磨剤を試験した。<Stain Removal Test 2> (1) Ten male subjects habitually smoke 20 or more cigarettes a day with a tar content of 10 mg or more. Five of the ten subjects used the dentifrice of Example 1 and the remaining five used the dentifrice of Comparative Example 1 for two days a week for one week.
Normal brushing was performed for about 3 minutes. After the use test for one week, a questionnaire describing the following evaluation criteria was given to each subject. After a one-month blank, the same use test was performed again, and the same questionnaire was performed. 1
The group using the dentifrice of Example 1 in the second use test uses the dentifrice of Comparative Example 1, and the group using the dentifrice of Comparative Example 1 in the first use test uses the dentifrice of Example 1. It was decided to. (2) The dentifrice of Example 3 and the dentifrice of Comparative Example 3 were tested in the same procedure as in the above test (1).
【0027】各歯磨剤の評価は、アンケート結果を基
に、10名の平均値を求め、下記の4段階で行った。 4<◎≦3 3<○≦2 2<△≦1 1<×≦0 「評価基準」 ステイン除去度合い 4・・・・・完全にステインが除去されている。 3・・・・・ほとんどステインが除去されている。 2・・・・・ややステインが除去されている。 1・・・・・全くステインが除去されていない。 結果は、実施例1の練歯磨剤について○、比較例1の練
歯磨剤について△、実施例3の歯磨き剤について◎、比
較例3の歯磨き剤について×であった。The evaluation of each dentifrice was based on the results of a questionnaire, the average value of 10 persons was determined, and the evaluation was performed in the following four stages. 4 <◎ ≦ 3 3 <○ ≦ 2 2 <△ ≦ 1 1 <× ≦ 0 “Evaluation criteria” Stain removal degree 4... Stain is completely removed. 3. Stain is almost completely removed. 2. Slight stain has been removed. 1... No stain is removed at all. The results were ○ for the toothpaste of Example 1, Δ for the toothpaste of Comparative Example 1, ◎ for the dentifrice of Example 3, and X for the dentifrice of Comparative Example 3.
【0028】以上の実験結果から,本発明による練歯磨
剤は、ステイン除去効果に優れていることが判った。ま
た下記に示す実施例9〜24についても上記の実験を行
ったところ,全て上記と同様な結果が得られた。以下、
実施例9〜24の練歯磨剤の組成を示す。配合量の単位
は質量%である。From the above experimental results, it was found that the toothpaste according to the present invention was excellent in the stain removing effect. In addition, when the above-described experiments were performed on Examples 9 to 24 described below, all the same results were obtained. Less than,
The composition of the toothpastes of Examples 9 to 24 is shown. The unit of the compounding amount is mass%.
【0029】[0029]
【実施例9】 Embodiment 9
【0030】[0030]
【実施例10】 Embodiment 10
【0031】[0031]
【実施例11】 Embodiment 11
【0032】[0032]
【実施例12】 Embodiment 12
【0033】[0033]
【実施例13】 Embodiment 13
【0034】[0034]
【実施例14】 Embodiment 14
【0035】[0035]
【実施例15】 Embodiment 15
【0036】[0036]
【実施例16】 Embodiment 16
【0037】[0037]
【実施例17】 Embodiment 17
【0038】[0038]
【実施例18】 Embodiment 18
【0039】[0039]
【実施例19】 Embodiment 19
【0040】[0040]
【実施例20】 Embodiment 20
【0041】[0041]
【実施例21】 Embodiment 21
【0042】[0042]
【実施例22】 Embodiment 22
【0043】[0043]
【実施例23】 Embodiment 23
【0044】[0044]
【実施例24】 Embodiment 24
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/28 A61K 7/28 (72)発明者 石井 良和 東京都八王子市南大沢2−216−3 光和 クレスト206 Fターム(参考) 4C083 AA112 AB222 AB291 AB292 AB321 AB322 AB372 AB472 AC122 AC132 AC312 AC432 AC472 AC482 AC582 AC622 AC662 AC692 AC712 AC742 AC782 AC792 AC842 AC862 AD041 AD042 AD071 AD072 AD212 AD272 AD352 AD472 AD532 AD662 CC41 DD22 EE35 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 7/28 A61K 7/28 (72) Inventor Yoshikazu Ishii 2-216-3 Minami-Osawa, Hachioji-shi, Tokyo Mitsuwa Crest 206 F-term (reference) 4C083 AA112 AB222 AB291 AB292 AB321 AB322 AB372 AB472 AC122 AC132 AC312 AC432 AC472 AC482 AC582 AC622 AC662 AC692 AC712 AC742 AC782 AC792 AC842 AC862 AD041 AD042 AD071 AD072 AD212 AD272 AD352 AD472 AD532 AD662 CC41 DD22 EE
Claims (1)
イト、炭酸アパタイト、第三リン酸カルシウム、第四リ
ン酸カルシウム及び第八リン酸カルシウムからなる群か
ら選ばれる少なくとも1種を0.1〜50質量%、平均分
子量200〜20,000のポリエチレングリコールの少
なくとも1種を0.1〜30質量%、及び平均分子量10,
000〜360,000のポリビニルピロリドンの少なく
とも1種を0.01〜3質量%含有することを特徴とする
口腔用組成物。1. At least one member selected from the group consisting of hydroxyapatite, fluoroapatite, carbonate apatite, tribasic calcium phosphate, quaternary calcium phosphate and calcium octaphosphate, in an amount of 0.1 to 50% by mass and an average molecular weight of 200 to 20,000. 0.1 to 30% by mass of polyethylene glycol having an average molecular weight of 10,
An oral composition comprising 0.01 to 3% by mass of at least one kind of polyvinylpyrrolidone of 000 to 360,000.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31839799A JP4126140B2 (en) | 1999-11-09 | 1999-11-09 | Oral composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31839799A JP4126140B2 (en) | 1999-11-09 | 1999-11-09 | Oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001131042A true JP2001131042A (en) | 2001-05-15 |
JP4126140B2 JP4126140B2 (en) | 2008-07-30 |
Family
ID=18098710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP31839799A Expired - Lifetime JP4126140B2 (en) | 1999-11-09 | 1999-11-09 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4126140B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002193775A (en) * | 2000-12-21 | 2002-07-10 | Lion Corp | Set for tooth bleaching |
WO2005000251A1 (en) * | 2003-06-30 | 2005-01-06 | Kabushiki Kaisha Sangi | Recalcification promoters and oral care compositions |
JP2011098921A (en) * | 2009-11-06 | 2011-05-19 | Lion Corp | Composition for oral cavity |
-
1999
- 1999-11-09 JP JP31839799A patent/JP4126140B2/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002193775A (en) * | 2000-12-21 | 2002-07-10 | Lion Corp | Set for tooth bleaching |
WO2005000251A1 (en) * | 2003-06-30 | 2005-01-06 | Kabushiki Kaisha Sangi | Recalcification promoters and oral care compositions |
JP2011098921A (en) * | 2009-11-06 | 2011-05-19 | Lion Corp | Composition for oral cavity |
Also Published As
Publication number | Publication date |
---|---|
JP4126140B2 (en) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004041229A1 (en) | Base for oral composition and oral composition | |
JP4723068B2 (en) | Oral composition base and oral composition | |
JP5196127B2 (en) | Oral composition | |
JP5420811B2 (en) | Oral composition | |
JP7447470B2 (en) | dentifrice composition | |
WO2018066341A1 (en) | Oral composition and method for suppressing discoloration of formulation and liquid separation thereof | |
JP2015117215A (en) | Dentifrice composition | |
JP4803889B2 (en) | Non-aqueous toothpaste | |
JP4126140B2 (en) | Oral composition | |
JP4257001B2 (en) | Oral composition | |
JPH1087458A (en) | Composition for oral cavity | |
JP4762429B2 (en) | Oral composition | |
JP2002302429A (en) | Composition for oral cavity | |
JP4632553B2 (en) | Oral composition | |
JP7076748B2 (en) | Oral composition | |
JP2002114656A (en) | Base material for composition for oral cavity and composition for oral cavity | |
JPH07187975A (en) | Composition for oral cavity | |
JP4377024B2 (en) | Oral composition | |
JP4257002B2 (en) | Oral composition | |
JP4892966B2 (en) | Dentifrice composition | |
CN111902125A (en) | Oral composition and bitterness improver for alpha-olefin sulfonate | |
JPH10236934A (en) | Oral composition | |
JP7602910B2 (en) | Oral Composition | |
JP7342688B2 (en) | Oral composition | |
JP2006199680A (en) | Toothpaste composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061109 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080415 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080421 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080512 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4126140 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110516 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130516 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140516 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |